Fennec Pharmaceuticals (NASDAQ: FENC) reported Q1 EPS of $0.01, $0.05 better than the analyst estimate of ($0.04). Revenue for the quarter came in at $15.11 million versus the consensus estimate of $14.65 million.

For earnings history and earnings-related data on Fennec Pharmaceuticals (FENC) click here.